Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions

Background. Drug-eluting stent (DES) plus drug-coated balloon (DCB) is a safe and effective treatment strategy for coronary artery bifurcation lesions, but there is no report about this strategy being used for left main (LM) bifurcation lesions. We aim to explore the efficacy and safety of DES plus...

Full description

Saved in:
Bibliographic Details
Main Authors: Hengdao Liu, Hailong Tao, Xufei Han, Yang Lu, Xiaofei Xue, Ruihan Feng, Fenghua Lv, Yanwei Liu, Hongrui Jin, Lianjie Li, Heping Gu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Interventional Cardiology
Online Access:http://dx.doi.org/10.1155/2022/8250057
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552244288946176
author Hengdao Liu
Hailong Tao
Xufei Han
Yang Lu
Xiaofei Xue
Ruihan Feng
Fenghua Lv
Yanwei Liu
Hongrui Jin
Lianjie Li
Heping Gu
author_facet Hengdao Liu
Hailong Tao
Xufei Han
Yang Lu
Xiaofei Xue
Ruihan Feng
Fenghua Lv
Yanwei Liu
Hongrui Jin
Lianjie Li
Heping Gu
author_sort Hengdao Liu
collection DOAJ
description Background. Drug-eluting stent (DES) plus drug-coated balloon (DCB) is a safe and effective treatment strategy for coronary artery bifurcation lesions, but there is no report about this strategy being used for left main (LM) bifurcation lesions. We aim to explore the efficacy and safety of DES plus DCB in the treatment of LM bifurcation lesions. Methods. A total of 100 patients diagnosed with LM bifurcation lesions by coronary angiography were retrospectively enrolled at our center from January 2018 to December 2019. They received either a two-stent strategy or a main branch (MB) stenting plus side branch (SB) DCB strategy and were accordingly divided into the 2-DES group and the DES + DCB group. Patients treated with DES + DCB were compared with a cohort of matched patients treated with a 2-DES strategy. Clinical data was collected and quantitative coronary analysis was performed. Results. For immediate postoperative angiography, though the two groups had no differences in the minimal luminal diameter (MLD) and luminal stenosis of MB, the DES + DCB group had significantly lower SB ostial MLD and a higher degree of residual lumen stenosis than the 2-DES group (P<0.05). At the time of follow-up, the SB ostial MLD of the DES + DCB group was higher than that of the 2-DES group, but lumen stenosis, late lumen loss (LLL), and LLL at the distal end of the left MB were all smaller than those of the 2-DES group (Ps<0.05). Furthermore, the incidence of lumen restenosis and MACE between the two groups had no significance. Conclusion. The combination of DES and DCB is relatively safe and effective for the treatment of LM bifurcation lesions, and this strategy seems to have advantages in reducing LLL at the SB ostium.
format Article
id doaj-art-aa2c8105a537468ca222e85fdeb5f12e
institution Kabale University
issn 1540-8183
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Interventional Cardiology
spelling doaj-art-aa2c8105a537468ca222e85fdeb5f12e2025-02-03T05:59:10ZengWileyJournal of Interventional Cardiology1540-81832022-01-01202210.1155/2022/8250057Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation LesionsHengdao Liu0Hailong Tao1Xufei Han2Yang Lu3Xiaofei Xue4Ruihan Feng5Fenghua Lv6Yanwei Liu7Hongrui Jin8Lianjie Li9Heping Gu10Department of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of Infectious DiseaseDepartment of Magnetic ResonanceDepartment of CardiologyDepartment of CardiologyBackground. Drug-eluting stent (DES) plus drug-coated balloon (DCB) is a safe and effective treatment strategy for coronary artery bifurcation lesions, but there is no report about this strategy being used for left main (LM) bifurcation lesions. We aim to explore the efficacy and safety of DES plus DCB in the treatment of LM bifurcation lesions. Methods. A total of 100 patients diagnosed with LM bifurcation lesions by coronary angiography were retrospectively enrolled at our center from January 2018 to December 2019. They received either a two-stent strategy or a main branch (MB) stenting plus side branch (SB) DCB strategy and were accordingly divided into the 2-DES group and the DES + DCB group. Patients treated with DES + DCB were compared with a cohort of matched patients treated with a 2-DES strategy. Clinical data was collected and quantitative coronary analysis was performed. Results. For immediate postoperative angiography, though the two groups had no differences in the minimal luminal diameter (MLD) and luminal stenosis of MB, the DES + DCB group had significantly lower SB ostial MLD and a higher degree of residual lumen stenosis than the 2-DES group (P<0.05). At the time of follow-up, the SB ostial MLD of the DES + DCB group was higher than that of the 2-DES group, but lumen stenosis, late lumen loss (LLL), and LLL at the distal end of the left MB were all smaller than those of the 2-DES group (Ps<0.05). Furthermore, the incidence of lumen restenosis and MACE between the two groups had no significance. Conclusion. The combination of DES and DCB is relatively safe and effective for the treatment of LM bifurcation lesions, and this strategy seems to have advantages in reducing LLL at the SB ostium.http://dx.doi.org/10.1155/2022/8250057
spellingShingle Hengdao Liu
Hailong Tao
Xufei Han
Yang Lu
Xiaofei Xue
Ruihan Feng
Fenghua Lv
Yanwei Liu
Hongrui Jin
Lianjie Li
Heping Gu
Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions
Journal of Interventional Cardiology
title Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions
title_full Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions
title_fullStr Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions
title_full_unstemmed Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions
title_short Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions
title_sort improved outcomes of combined main branch stenting and side branch drug coated balloon versus two stent strategy in patients with left main bifurcation lesions
url http://dx.doi.org/10.1155/2022/8250057
work_keys_str_mv AT hengdaoliu improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT hailongtao improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT xufeihan improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT yanglu improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT xiaofeixue improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT ruihanfeng improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT fenghualv improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT yanweiliu improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT hongruijin improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT lianjieli improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions
AT hepinggu improvedoutcomesofcombinedmainbranchstentingandsidebranchdrugcoatedballoonversustwostentstrategyinpatientswithleftmainbifurcationlesions